Immunohematology Market USD 1,850.5 Million in 2023

The global Immunohematology market was valued at USD 1,850.5 Million in 2022 and is estimated to reach USD 2,678.9 Million by 2032, growing at a CAGR of 5%. Immunohematology is a branch of hematology which focuses on studying antibody-antigen reactions as they may lead to hemolysis or RBC agglutination. Commonly known as “Blood Banking” or “Blood Biology,” Immunohematology facilitates the screening of components such as RBCs, White blood cells of the donor’s blood, and prepares these blood components for transfusion. It plays a crucial role in reducing incompatibility between the donor’s blood and receiver’s blood and further eliminates the chances of infections such as thalassemia and HIV.

High incidence of hematological diseases, rise in the number of trauma cases, increasing demand for platelets, plasma factors and immunoglobin, and increased awareness regarding the importance of blood-transfusion related diseases & medical care are the key factors augmenting the market growth. Government and private institutions are investing significantly in the development of blood banks. This would surge the demand for immunohematology devices, thereby favorably impacting market growth.

Request a Sample@

Recently, rapid technological advancements in immunohematology have paved the way for the development of a diagnostic approach towards in vitro study of compatibility between the donor’s and receiver’s blood. Some of the key technological advancements include automation of the immunohematology devices, advanced testing devices, and new transfusion techniques. The fully automated immunohematology devices perform blood screening tests and deliver accurate results and further simplifying the identification process. Advanced antiglobulin screening instruments and assays validate for proper blood typing. These developments have enabled clinics and hospitals to provide emergency assistance. The companies are focusing on improving the safety and longevity of blood stored in blood banks by innovating advanced immunohematology devices. Companies are investing in Research and Development for innovating advanced immunohematology devices. The fully-automated devices such as analyzers that are capable of conducting automated tests of the blood samples are in high demand from hospitals & blood banks. Furthermore, For instance, Bio-Rad Laboratories launched IH-1000 in 2016, which offers automation and extended walk-away autonomy, allowing laboratories to more efficiently manage their blood testing workload. Moreover, they offer customers in the U.S. a wide variety of platforms, reagents, data management, and connectivity solutions to address different volume blood testing needs.

However, factors such as high initial investments, inadequate reimbursements of high-tech devices, and lack of awareness of technologically advanced devices in developed and developing countries hamper the market growth globally, thereby reducing the sales of immunohematology devices. Additionally, the research organization is trying to moderate the costs of R&D. Considering these hindrances, manufacturers are allowing the users to rent advanced reagents and analyzers. Reagent rentals or leasing analyzers are expected to emerge as one of the most popular trends in the immunohematology market in the future.

Salient Trends of the Immunohematology Market

  • The global immunohematology market is expected to witness robust growth given the increase in trauma cases, technological developments and rising demand for platelets, plasma factors and immunoglobin
  • With respect to product segmentation of the market, immunohematology reagents held the largest market share owing to their extensive use in immunohematology tests and high demand from blood banks
  • The immunohematology analyzer product segment is further sub-segmented into automatic analyzers and semi-automatic/non-automatic analyzers. The automatic analyzers segment is projected to be the fastest growing segment because of their efficiency in delivery accurate tests by using less reagents
  • The automated analyzers function on the basis of some reagents. This interdependence between reagents and analyzers impacts the overall market growth positively
  • In regards to end-users, Hospitals form the largest segment capturing a dominant market share. It is crucial for the hospitals to screen the donor’s blood for any infections as well as for its compatibility with the receiver’s blood
  • North America is the leading regional segment in terms of revenue generation. Adoption of advanced technology as well as preference for automated devices are augmenting the market growth in the region. Furthermore, U.S FDA provides clearance to many innovation products which encourages the companies to invest more in R&D. For instance, FDA clears ORTHO Sera ID-MTS for use on the ORTHO VISION Analyzer, fully automated technology from ortho clinical diagnostics aids in extended antigen phenotyping and ensures delivery of safe blood to transfusion Patients
  • APAC region is prophesied to be the fastest growing region during the forecast period owing to the gradual adoption of advanced treatment options, increased healthcare spending and availability of superior treatment facilities at lower prices in countries such as India & China.

Companies considered and profiled in this market study

The Global Immunohematology Market study postulates constructive intuition globally which includes the companies who are the key players in Global Immunohematology Market, such as Siemens Healthcare GmbH, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Grifols, Immucor, Abbott laboratories, Beckman Coulter, ThermoFisher, Becton Dickinson and Merck KGaA


  • Asia Pacific region is forecasted to be the fastest growing regional segment registering a CAGR of 5.8% followed by Europe and North America with 4.9% and 4.6% respectively
  • The Immunohematology analyzers market was values at USD 778.8 million. The segment is expected to register a highest CAGR during the forecast period owing to rapid technological developments and innovation of automated analyzers
  • In the forecast year 2023, Immunohematology reagents segment dominated the global immunohematology market with a massive share of 54.5%
  • With respect to end-use market segmentation, Hospitals is projected to be the dominant segment with a CAGR of 4.8%. The crucial importance of Immunohematology devices in hospitals proliferates the market growth
  • Blood banks segment is the fastest growing segment which is expected to register the highest CAGR of 5.5% owing to rapid construction of Blood banks by private and government institutions
  • North America is expected to have the largest market. It is projected to maintain its lead in the global market given the adoption of advanced devices and products and high investments in R&D
  • Europe is the second largest region in terms of revenue generation with a share of 31.2% followed by APAC region

Key Coverage of the Report

  • Region and country-wise assessment from the period 2016-2026. For the study, 2016-2017 has been utilized as historical data, 2023 as the base year, and 2019-2026, has been derived as forecasts
  • Regional Competitors clinical pipeline analysis
  • Demand and Supply GAP Analysis
  • Market share analysis of the key industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments

Segments covered in the report

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2023 to 2032. For the purpose of this study, have segmented the Immunohematology market on the basis of Product, Application, Disease, End-use, and region:

Product (Revenue, USD Million; 2023–2032)

  • Immunohematology Reagents
  • Immunohematology Analyzers
    • Automated Analyzers
    • Semi-automated analyzers / Non-automated analyzers

Application (Revenue, USD Million; 2023–2032)

  • Pretransfusion testing
    • ABO and Rh Typing
    • Antibody Detection
    • Cross matching
  • Investigation of immune hemolysis
  • Perinatal testing
  • Blood group Phenotyping / genotyping
  • Leucocyte and platelet Serology

Disease (Revenue, USD Million; 2023–2032)

  • Blood-related diseases
  • HIV
  • Hepatitis

End-use (Revenue, USD Million; 2023–2032)

  • Hospitals
  • Blood banks
  • Diagnostic laboratories

Regional Outlook (Revenue in USD Million; 2023–2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil

Buy quantitative research Report at discounted price – USD 1500

You can place an order or ask any questions, please feel free to contact | +1 9197 992 333



About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:


Leave a Comment

Your email address will not be published. Required fields are marked *